mRNA vaccines induce rapid antibody responses in mice
Abstract mRNA vaccines can be developed and produced quickly, making them prime candidates for immediate outbreak responses. Furthermore, clinical trials have demonstrated rapid protection following mRNA vaccination. Thus, we sought to investigate how quickly mRNA vaccines elicit antibody responses...
Hoofdauteurs: | Makda S. Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Xiaowen Liu, Andrew C. Cole, Stefan O. Mueller, Benjamin Petsch, Dan H. Barouch |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
Nature Portfolio
2022-08-01
|
Reeks: | npj Vaccines |
Online toegang: | https://doi.org/10.1038/s41541-022-00511-y |
Gelijkaardige items
-
mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
door: Susanne Rauch, et al.
Gepubliceerd in: (2021-04-01) -
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
door: Nicole Roth, et al.
Gepubliceerd in: (2022-08-01) -
mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
door: Charlie Fricke, et al.
Gepubliceerd in: (2024-12-01) -
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
door: Nicole Roth, et al.
Gepubliceerd in: (2023-01-01) -
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
door: Björn Corleis, et al.
Gepubliceerd in: (2023-02-01)